Cargando…

Circulating insulin-like growth factors and Alzheimer disease: A mendelian randomization study

OBJECTIVE: To examine whether genetically predicted variation in circulating insulin-like growth factor 1 (IGF1) or its binding protein, IGFBP3, are associated with risk of Alzheimer disease (AD), using a mendelian randomization study design. METHODS: We first examined disease risk by genotypes of 9...

Descripción completa

Detalles Bibliográficos
Autores principales:	Williams, Dylan M., Karlsson, Ida K., Pedersen, Nancy L., Hägg, Sara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5798653/ https://www.ncbi.nlm.nih.gov/pubmed/29282328 http://dx.doi.org/10.1212/WNL.0000000000004854

Ejemplares similares

Circulating antioxidants and Alzheimer disease prevention: a Mendelian randomization study
por: Williams, Dylan M, et al.
Publicado: (2019)

Circulating insulin-like growth factor-1 and risk of lung diseases: A Mendelian randomization analysis
por: Jiang, Sujing, et al.
Publicado: (2023)

Circulating Insulin-Like Growth Factor 1 Levels and Migraine Risk: A Mendelian Randomization Study
por: Abuduxukuer, Reziya, et al.
Publicado: (2022)

Genetically-predicted life-long lowering of low-density lipoprotein cholesterol is associated with decreased frailty: A Mendelian randomization study in UK biobank
por: Wang, Qi, et al.
Publicado: (2019)

Polyunsaturated fatty acids and risk of Alzheimer’s disease: a Mendelian randomization study
por: Tomata, Yasutake, et al.
Publicado: (2019)

Circulating Levels of Insulin-like Growth Factor 1 and Insulin-like Growth Factor Binding Protein 3 Associate With Risk of Colorectal Cancer Based on Serologic and Mendelian Randomization Analyses
por: Murphy, Neil, et al.
Publicado: (2020)

Leukocyte DNA methylation in Alzheimer´s disease associated genes: replication of findings from neuronal cells
por: Karlsson, Ida K, et al.
Publicado: (2022)

Tumor Necrosis Factor Inhibition and Parkinson Disease: A Mendelian Randomization Study
por: Kang, Xiaoying, et al.
Publicado: (2021)

Circulating Glutamine and Alzheimer’s Disease: A Mendelian Randomization Study
por: Adams, Charleen D
Publicado: (2020)

Assessing the role of insulin‐like growth factors and binding proteins in prostate cancer using Mendelian randomization: Genetic variants as instruments for circulating levels
por: Bonilla, Carolina, et al.
Publicado: (2016)

Genetic Variation in Targets of Antidiabetic Drugs and Alzheimer Disease Risk: A Mendelian Randomization Study
por: Tang, Bowen, et al.
Publicado: (2022)

Insulin‐like growth factor‐1 and site‐specific cancers: A Mendelian randomization study
por: Larsson, Susanna C., et al.
Publicado: (2020)

Lipid lowering and Alzheimer disease risk: A mendelian randomization study
por: Williams, Dylan M., et al.
Publicado: (2019)

Insulin-like Growth Factor-1, Bone Mineral Density, and Fracture: A Mendelian Randomization Study
por: Yuan, Shuai, et al.
Publicado: (2021)

Insulin-like growth factor-1, insulin-like growth factor-binding protein-3, and breast cancer risk: observational and Mendelian randomization analyses with ∼430 000 women
por: Murphy, N., et al.
Publicado: (2020)

Evidence of a Causal Relationship Between Adiponectin Levels and Insulin Sensitivity: A Mendelian Randomization Study
por: Gao, He, et al.
Publicado: (2013)

Fatty Acids and Frailty: A Mendelian Randomization Study
por: Tomata, Yasutake, et al.
Publicado: (2021)

Circulating insulin-like growth factors and risks of overall, aggressive and early-onset prostate cancer: a collaborative analysis of 20 prospective studies and Mendelian randomization analysis
por: Watts, Eleanor L, et al.
Publicado: (2022)

Protein Nutritional Status and Frailty: A Mendelian Randomization Study
por: Tomata, Yasutake, et al.
Publicado: (2021)

Unraveling the genetic complexity of Alzheimer disease with Mendelian Randomization
por: Bandres-Ciga, Sara, et al.
Publicado: (2019)

Circulating vascular endothelial growth factor and cancer risk: A bidirectional mendelian randomization
por: Wu, Hong, et al.
Publicado: (2022)

Apolipoprotein E DNA methylation and late-life disease
por: Karlsson, Ida K, et al.
Publicado: (2018)

The causes and consequences of Alzheimer’s disease: phenome-wide evidence from Mendelian randomization
por: Korologou-Linden, Roxanna, et al.
Publicado: (2022)

A Frailty Index for UK Biobank Participants
por: Williams, Dylan M, et al.
Publicado: (2019)

Association between genetically predicted telomere length and facial skin aging in the UK Biobank: a Mendelian randomization study
por: Zhan, Yiqiang, et al.
Publicado: (2020)

Circulating biomarkers of immunity and inflammation, risk of Alzheimer’s disease, and hippocampal volume: a Mendelian randomization study
por: Fani, Lana, et al.
Publicado: (2021)

Meta-Analysis of Serum Insulin-Like Growth Factor 1 in Alzheimer’s Disease
por: Ostrowski, Philip P., et al.
Publicado: (2016)

The epigenetic etiology of cardiovascular disease in a longitudinal Swedish twin study
por: Qin, Xueying, et al.
Publicado: (2021)

On the use of Mendelian randomization to assess the consequences of metformin exposure
por: Williams, Dylan M
Publicado: (2020)

The neglected role of insulin-like growth factors in the maternal circulation regulating fetal growth
por: Sferruzzi-Perri, A N, et al.
Publicado: (2011)

Causal associations between insulin-like growth factor 1 and vitamin D levels: a two-sample bidirectional Mendelian randomization study
por: Gou, Zhaoyang, et al.
Publicado: (2023)

Stroke and Alzheimer’s Disease: A Mendelian Randomization Study
por: Wang, Tao, et al.
Publicado: (2020)

Alzheimer Disease and Epilepsy: A Mendelian Randomization Study
por: Fang, Yi, et al.
Publicado: (2023)

Frailty and the risk of dementia: is the association explained by shared environmental and genetic factors?
por: Bai, Ge, et al.
Publicado: (2021)

Insulin and insulin-like growth factor-I receptors in astrocytes exert different effects on behavior and Alzheimer´s-like pathology
por: Zegarra-Valdivia, Jonathan, et al.
Publicado: (2022)

Evaluating Lipid‐Lowering Drug Targets for Parkinson's Disease Prevention with Mendelian Randomization
por: Williams, Dylan M., et al.
Publicado: (2020)

Parkinson’s disease and Alzheimer’s disease: a Mendelian randomization study
por: Han, Zhifa, et al.
Publicado: (2018)

Role of Insulin-like Growth Factor, Insulin-like Growth Factor Receptors, and Insulin-like Growth Factor-binding Proteins in Ovarian Cancer
por: Amutha, Periyasamy, et al.
Publicado: (2017)

Circulating metabolites and depression: a bidirectional Mendelian randomization
por: Dong, Yankai, et al.
Publicado: (2023)

Insulin‐like growth factor‐2 is a promising candidate for the treatment and prevention of Alzheimer's disease
por: Fitzgerald, G. S., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_u7663digd7ubhbt4v9apevpgnb